BSX vs PWP · P/E 20, rev $16.75B vs rev $878.0M
Boston Scientific Corp (BSX) versus Perella Weinberg Partners (PWP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Perella Weinberg Partners (PWP) is a capital markets company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported PWP revenue for 2024-12-31 was $878.0M. Net income was -$89.3M. Revenue was up 35.4% from 2023-12-31 to 2024-12-31. PWP currently screens at market cap $1.82B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. PWP currently screens at market cap $1.82B.
Not investment advice. Open the BSX and PWP stock pages for the full models.
Not investment advice.